Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
2.6K
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

813
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
813
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.4K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer Genetic Risk Assessment (CGRA) Certification: Outcomes from the First Six Years.

European journal of breast health·2026
Same author

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2026
Same author

Cancer Risk Assessment and Hereditary Cancer Genetic Testing in a Community OBGYN Setting.

European journal of breast health·2026
Same author

Model-Twin Randomization (MoTR) for Estimating the Recurring Individual Treatment Effect.

Statistics in medicine·2025
Same author

Insights into maternal sleep: a large-scale longitudinal analysis of real-world wearable device data before, during, and after pregnancy.

EBioMedicine·2025
Same author

Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing.

Obstetrics and gynecology·2024

Related Experiment Video

Updated: Apr 30, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.6K

Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health

Elaine Mielcarski1, Dana Karanik1, Heather Bagley2

  • 1Associates for Women's Medicine, North Syracuse, New York.

Journal of Midwifery & Women'S Health
|April 28, 2026
PubMed
Summary

Workflow innovations significantly improved hereditary cancer risk assessments (HCRAs) and genetic testing completion rates among advanced practice providers (APPs). APPs reported increased confidence and better adherence to standards of care, enhancing women's health services.

Keywords:
advanced practice providersgenetic testinghereditary cancer risk assessmentsmidwivesnurse practitionersonline patient screeningquality improvementvirtual patient educationworkflow optimization

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

12.8K
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

769

Related Experiment Videos

Last Updated: Apr 30, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.6K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

12.8K
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

769

Area of Science:

  • Women's Health
  • Genetics
  • Oncology

Background:

  • Advanced practice providers (APPs) are crucial for meeting women's health demands.
  • APPs can perform hereditary cancer risk assessments (HCRAs) and genetic evaluations, similar to physicians.
  • Barriers like time constraints and limited confidence can impede APPs' integration of HCRA and genetic testing.

Purpose of the Study:

  • To implement and evaluate workflow innovations to enhance HCRA and genetic testing by APPs.
  • To assess the impact of these innovations on genetic testing uptake and completion rates.
  • To evaluate APP confidence and practice integration of HCRA tools.

Main Methods:

  • A prospective, single-arm quality improvement initiative.
  • Introduction of workflow innovations, including online screening and virtual patient education tools.
  • Pre- and post-intervention data collection on genetic testing metrics and APP experiences; statistical analysis.

Main Results:

  • Significant increases observed in offering genetic testing (+27.1%) and testing completion rates (+26.4%).
  • High APP agreement that workflow modifications improved confidence (91.7%), standard of care (91.7%), and guideline adherence (83.3%).
  • Improved ease of practice integration was reported by 66.7% of APPs.

Conclusions:

  • Standardized workflows and novel tools empower APPs to effectively provide personalized, evidence-based HCRAs.
  • APPs are capable of implementing new processes to deliver high-quality genetic evaluations.
  • These improvements support APPs in meeting the standard of care for hereditary cancer risk assessment.